Laura Custer

1.8k total citations
22 papers, 673 citations indexed

About

Laura Custer is a scholar working on Cancer Research, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Laura Custer has authored 22 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 8 papers in Molecular Biology and 8 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Laura Custer's work include Carcinogens and Genotoxicity Assessment (17 papers), Effects and risks of endocrine disrupting chemicals (6 papers) and Computational Drug Discovery Methods (6 papers). Laura Custer is often cited by papers focused on Carcinogens and Genotoxicity Assessment (17 papers), Effects and risks of endocrine disrupting chemicals (6 papers) and Computational Drug Discovery Methods (6 papers). Laura Custer collaborates with scholars based in United States, United Kingdom and Germany. Laura Custer's co-authors include Peter C. Jurs, Greg M. Pearl, Kevin Sweder, Stephen K. Durham, Susanne Glowienke, David Brusick, Jan A. Gossen, B. Myhr, Jan Vijg and David P. Gibson and has published in prestigious journals such as Biochemistry, Chemical Research in Toxicology and Mutation research. Fundamental and molecular mechanisms of mutagenesis.

In The Last Decade

Laura Custer

22 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Custer United States 16 306 213 175 164 101 22 673
Andreas Czich Germany 19 274 0.9× 293 1.4× 168 1.0× 175 1.1× 79 0.8× 30 875
Susanne Glowienke Switzerland 16 237 0.8× 136 0.6× 221 1.3× 172 1.0× 59 0.6× 28 700
Krista L. Dobo United States 20 420 1.4× 289 1.4× 199 1.1× 241 1.5× 114 1.1× 42 947
Jacky Van Gompel Belgium 12 267 0.9× 216 1.0× 106 0.6× 142 0.9× 100 1.0× 18 668
John Nicolette United States 10 209 0.7× 152 0.7× 92 0.5× 130 0.8× 52 0.5× 20 469
Lars Rohrbach United States 9 324 1.1× 141 0.7× 167 1.0× 209 1.3× 75 0.7× 11 562
Angela White United Kingdom 10 180 0.6× 100 0.5× 131 0.7× 97 0.6× 49 0.5× 22 427
Gilles Klopman United States 12 196 0.6× 134 0.6× 212 1.2× 120 0.7× 49 0.5× 19 533
Wera Teubner Germany 14 126 0.4× 279 1.3× 68 0.4× 116 0.7× 105 1.0× 23 999
Atsushi Hakura Japan 20 552 1.8× 499 2.3× 56 0.3× 185 1.1× 211 2.1× 63 1.1k

Countries citing papers authored by Laura Custer

Since Specialization
Citations

This map shows the geographic impact of Laura Custer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Custer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Custer more than expected).

Fields of papers citing papers by Laura Custer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Custer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Custer. The network helps show where Laura Custer may publish in the future.

Co-authorship network of co-authors of Laura Custer

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Custer. A scholar is included among the top collaborators of Laura Custer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Custer. Laura Custer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Snodin, David J., Alejandra Trejo‐Martin, David J. Ponting, et al.. (2024). Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic Potency. Chemical Research in Toxicology. 37(2). 181–198. 28 indexed citations
2.
Trejo‐Martin, Alejandra, Joel P. Bercu, Rachael E. Tennant, et al.. (2022). Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines. Regulatory Toxicology and Pharmacology. 135. 105247–105247. 31 indexed citations
3.
Nicolette, John, Mirjam Luijten, Jennifer C. Sasaki, et al.. (2021). Utility of a next‐generation framework for assessment of genomic damage: A case study using the pharmaceutical drug candidate etoposide. Environmental and Molecular Mutagenesis. 62(9). 512–525. 5 indexed citations
4.
Reynolds, Vincent L., Paul Butler, Laura Aschenbrenner, et al.. (2020). Nonclinical safety assessment of epigenetic modulatory drugs: Current status and industry perspective. Regulatory Toxicology and Pharmacology. 117. 104746–104746. 1 indexed citations
5.
Lovell, David P., Mick D. Fellows, James Whitwell, et al.. (2019). Analysis of historical negative control group data from the rat in vivo micronucleus assay. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 849. 503086–503086. 2 indexed citations
6.
Bercu, Joel P., Sheila M. Galloway, Andrew Teasdale, et al.. (2018). Potential impurities in drug substances: Compound-specific toxicology limits for 20 synthetic reagents and by-products, and a class-specific toxicology limit for alkyl bromides. Regulatory Toxicology and Pharmacology. 94. 172–182. 36 indexed citations
7.
Gleason, Carol, et al.. (2016). Novel statistical approach for evaluating flow cytometric in vitro micronucleus data. Environmental and Molecular Mutagenesis. 57(8). 623–629. 3 indexed citations
8.
Barber, Chris, Alexander Amberg, Laura Custer, et al.. (2015). Establishing best practise in the application of expert review of mutagenicity under ICH M7. Regulatory Toxicology and Pharmacology. 73(1). 367–377. 51 indexed citations
9.
Sutter, Andreas, Alexander Amberg, Scott Boyer, et al.. (2013). Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities. Regulatory Toxicology and Pharmacology. 67(1). 39–52. 88 indexed citations
10.
Torous, Dorothea K., Souk Phonethepswath, Svetlana L. Avlasevich, et al.. (2012). In vivo flow cytometric Pig‐a and micronucleus assays: Highly sensitive discrimination of the carcinogen/noncarcinogen pair benzo(a)pyrene and pyrene using acute and repeated‐dose designs. Environmental and Molecular Mutagenesis. 53(6). 420–428. 19 indexed citations
11.
Escobar, Patricia A., Raymond A. Kemper, John Nicolette, et al.. (2012). Bacterial mutagenicity screening in the pharmaceutical industry. Mutation Research/Reviews in Mutation Research. 752(2). 99–118. 49 indexed citations
12.
Lynch, Anthony M., Amanda Giddings, Laura Custer, et al.. (2011). International Pig‐a gene mutation assay trial (Stage III): Results with N‐methyl‐N‐nitrosourea. Environmental and Molecular Mutagenesis. 52(9). 699–710. 38 indexed citations
13.
Dearfield, Kerry L., Véronique Thybaud, Michael C. Cimino, et al.. (2010). Follow‐up actions from positive results of in vitro genetic toxicity testing. Environmental and Molecular Mutagenesis. 52(3). 177–204. 37 indexed citations
14.
Custer, Laura & Kevin Sweder. (2008). The Role of Genetic Toxicology in Drug Discovery and Optimization. Current Drug Metabolism. 9(9). 978–985. 36 indexed citations
15.
Jurs, Peter C., et al.. (2005). Probabilistic Neural Network Multiple Classifier System for Predicting the Genotoxicity of Quinolone and Quinoline Derivatives. Chemical Research in Toxicology. 18(3). 428–440. 6 indexed citations
16.
Mattioni, Brian, Gregory W. Kauffman, Peter C. Jurs, et al.. (2003). Predicting the Genotoxicity of Secondary and Aromatic Amines Using Data Subsetting To Generate a Model Ensemble. Journal of Chemical Information and Computer Sciences. 43(3). 949–963. 38 indexed citations
17.
Jurs, Peter C., et al.. (2003). Predicting the Genotoxicity of Polycyclic Aromatic Compounds from Molecular Structure with Different Classifiers. Chemical Research in Toxicology. 16(12). 1567–1580. 30 indexed citations
18.
Mosier, Philip D., Peter C. Jurs, Laura Custer, Stephen K. Durham, & Greg M. Pearl. (2003). Predicting the Genotoxicity of Thiophene Derivatives from Molecular Structure. Chemical Research in Toxicology. 16(6). 721–732. 35 indexed citations
19.
Custer, Laura, David P. Gibson, Marilyn J. Aardema, & Robert A. LeBœuf. (2000). A refined protocol for conducting the low pH 6.7 Syrian hamster embryo (SHE) cell transformation assay. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 455(1-2). 129–139. 15 indexed citations
20.
Custer, Laura, et al.. (1993). Detection of chemical mutagens using Muta® Mouse: a transgenic mouse model. Mutagenesis. 8(1). 7–10. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Czich Breakdown of academic impact, for papers by Susanne Glowienke Breakdown of academic impact, for papers by Krista L. Dobo Breakdown of academic impact, for papers by Jacky Van Gompel Breakdown of academic impact, for papers by John Nicolette Breakdown of academic impact, for papers by Lars Rohrbach Breakdown of academic impact, for papers by Angela White Breakdown of academic impact, for papers by Gilles Klopman Breakdown of academic impact, for papers by Wera Teubner Breakdown of academic impact, for papers by Atsushi Hakura
Rankless by CCL
2026